Synaptogenix, Inc.
SNPX
$2.50
$0.09023.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.75M | 1.14M | 1.24M | 1.08M | 1.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.18M | 1.36M | 1.58M | 1.69M | 2.13M |
| Operating Income | -2.18M | -1.36M | -1.58M | -1.69M | -2.13M |
| Income Before Tax | -5.55M | -5.74M | -1.27M | -206.70K | -996.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.55M | -5.74M | -1.27M | -206.70K | -996.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.55M | -5.74M | -1.27M | -206.70K | -996.00K |
| EBIT | -2.18M | -1.36M | -1.58M | -1.69M | -2.13M |
| EBITDA | -2.18M | -1.36M | -1.58M | -1.69M | -2.13M |
| EPS Basic | -4.17 | -4.58 | -1.18 | -0.41 | -1.45 |
| Normalized Basic EPS | -1.19 | -2.72 | -0.66 | -0.12 | -0.73 |
| EPS Diluted | -4.17 | -4.58 | -1.18 | -0.41 | -1.45 |
| Normalized Diluted EPS | -1.19 | -2.72 | -0.66 | -0.12 | -0.73 |
| Average Basic Shares Outstanding | 1.36M | 1.32M | 1.21M | 1.04M | 847.10K |
| Average Diluted Shares Outstanding | 1.36M | 1.32M | 1.21M | 1.04M | 847.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | -16.56% | -- | -- | -0.01% |